GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
33 hedge funds and large institutions have $23.9M invested in Genocea Biosciences, Inc. in 2020 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
33
Holding in Top 10
1
Calls
$2.79M
Puts
$23K
Top Buyers
| 1 | +$111K | |
| 2 | +$44.9K | |
| 3 | +$43K | |
| 4 |
Bank of New York Mellon
New York
|
+$35K |
| 5 |
WG
Winton Group
London,
United Kingdom
|
+$30K |
Top Sellers
| 1 | -$217K | |
| 2 | -$169K | |
| 3 | -$123K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$69K |
| 5 |
Millennium Management
New York
|
-$53.9K |